Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
10.7M
-
Shares change
-
-12.3K
-
Total reported value, excl. options
-
$28.7M
-
Value change
-
-$162K
-
Put/Call ratio
-
0.42
-
Number of buys
-
20
-
Number of sells
-
-24
-
Price
-
$2.69
Significant Holders of Summit Therapeutics Inc. - COM (SMMT) as of Q4 2021
58 filings reported holding SMMT - Summit Therapeutics Inc. - COM as of Q4 2021.
Summit Therapeutics Inc. - COM (SMMT) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.7M shares
.
Largest 10 shareholders include Polar Capital Holdings Plc (6.12M shares), BlackRock Inc. (1.4M shares), VANGUARD GROUP INC (907K shares), BAILLIE GIFFORD & CO (437K shares), STATE STREET CORP (337K shares), GEODE CAPITAL MANAGEMENT, LLC (249K shares), Russell Investments Group, Ltd. (217K shares), NORTHERN TRUST CORP (193K shares), UBS Group AG (116K shares), and WELLS FARGO & COMPANY/MN (84.5K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.